Table 2.

Predictors of screening participation among patients with cirrhosis enrolled in a pragmatic randomized controlled intervention trial, N = 1800.

Variable	Univariable Models OR (95% CI)	Multivariable Model AOR (95% CI)
Outreach Strategy  Usual Care  Outreach Alone  Outreach and Patient Navigation	Ref. 3.02 (2.32 – 3.92) 3.34 (2.57 – 4.34)	Ref. 3.18 (2.43 – 4.16) 3.47 (2.65 – 4.53)
Age (years)  21-50  51-60  61-90	Ref. 1.52 (1.20 – 1.93) 1.39 (1.06 – 1.81)	Ref. 1.42 (1.09 – 1.84) 1.15 (0.86 – 1.55)
Male sex	0.77 (0.64 – 0.94)	0.80 (0.65 – 0.99)
Race/Ethnicity  Non-Hispanic White  Hispanic  Non-Hispanic Black  Other/Unknown	Ref. 1.52 (1.19 – 1.95) 1.21 (0.94 – 1.57) 1.13 (0.52 – 2.46)	Ref. 1.56 (1.20 – 2.02) 1.14 (0.87 – 1.50) 1.23 (0.54 – 2.80)
Charlson Comorbidity Index  0  1  2  3+	Ref. 1.49 (1.04 – 2.11) 1.85 (1.27 – 2.69) 1.88 (1.36 – 2.59)	Ref. 1.31 (0.91 – 1.91) 1.60 (1.06 – 2.41) 1.41 (0.97 – 2.04)
Documented vs. suspected cirrhosis  Documented cirrhosis  Suspected cirrhosis	Ref. 1.26 (0.98 – 1.61)	Ref. 0.82 (0.62 – 1.09)
Child Pugh score  Child Pugh A  Child Pugh B	Ref. 1.32 (1.07 – 1.63)	Ref. 1.04 (0.79 – 1.38)
Hepatic decompensation  No  Yes	Ref. 1.41 (1.15 – 1.73)	Ref. 1.14 (0.87 – 1.50)
Etiology of Liver Disease  Hepatitis C  Hepatitis B  Alcohol-induced  Nonalcoholic steatohepatitis  Other	Ref. 0.64 (0.36 – 1.16) 1.0 (0.76 – 1.30) 1.16 (0.88 – 1.52) 0.74 (0.53 – 1.03)	NS
Number of primary care visitsa	1.07 (1.05 – 1.09)	1.05 (1.03 – 1.08)
Receipt of gastroenterology carea	2.01 (1.62 – 2.49)	1.74 (1.36 – 2.21)

OR = Odds Ratio; AOR = Adjusted Odds Ratio; CI = Confidence Interval

^aWithin one year preceding randomization